AI Resilience Report forEndoscopy Technicians

Right now, AI in the endoscopy world is mostly about augmenting doctors, not replacing the technicians who support them. The most common tools are "computer-aided detection" (CADe) systems that watch the video feed during a colonoscopy and highlight possible polyps in real time. Penn Gastroenterology introduced GI Genius™, the first FDA-approved device to use AI for colon polyp detection during colonoscopy, which superimposes real-time markers on the endoscopic camera video feed suggesting the presence of a potential lesion.

A February 2026 review in Practical Gastro ^[1] notes that more than 40 randomized trials have demonstrated the benefit of CADe in increasing polyp detection, though real-world data have been more variable. A July 2026 update in Diagnostics ^[2] explains that AI is evolving from a supportive adjunct into an increasingly integrated component of gastrointestinal endoscopy with the potential to improve procedural quality, diagnostic consistency, and clinical efficiency. Importantly, the hands-on tech tasks — positioning patients, attaching monitors, handing instruments, cleaning scopes — are not being automated, because a July 2026 editorial in Gastrointestinal Endoscopy ^[3]00138-0/fulltext) frames AI purely as a lesion-detection aid alongside human clinicians.

Adoption is moving quickly on the image analysis side and slowly on the staffing side. Becker's ASC reported in December 2025 ^[4] that GI practices are deploying AI visual interfaces during colonoscopy to help detect precancerous lesions and using AI for scheduling, triage and patient workflow optimization, and that practices will need to invest in staff training, data infrastructure and quality-assurance systems — meaning humans stay central. Cost is still a real speed bump: Penn Medicine notes that remaining challenges include the additional financial costs of new technology and insurance reimbursement.

Meanwhile, rising cancer-screening demand and staffing shortages make techs more valuable, not less. Becker's highlights that early-onset GI cancers are rising sharply, reshaping screening demand, with the U.S. seeing a 2.16% annual increase in early-onset GI cancer incidence from 2010 to 2019. So if you're considering this career: your calm hands, patient care, and equipment know-how are exactly what AI can't do — you'll likely work alongside these tools, not be replaced by them.